Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

3969 results

Sort By:

MedSMA℞T Mobile ED

Study ID: NCT06848504
Start Date: 2026-06
End Date: 2028-12
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

244

Intervention / Treatment

MedSMA℞T Mobile

Sponsor

The Funuch Abraham

Source: clinicaltrials.gov

Share:
Add to list

Clinical Efficacy of Exoskeleton Assistance for Individuals Post-Stroke

Study ID: NCT06064604
Start Date: 2027-01-01
End Date: 2028-12-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

30

Intervention / Treatment

Control

Hip Exoskeleton

Ankle Exoskeleton

Sponsor

Georgia Institute of Technology

Source: clinicaltrials.gov

Share:
Add to list

InterTAN: Integrated Dual Screw Design Improve Biomechanics/Function Following Fixation Surgery

Study ID: NCT06024304
Start Date: 2025-08-01
End Date: 2027-01-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

30

Intervention / Treatment

Synthes TFNA

Trigen intethen

Sponsor

Paul E. Matuszewski

Source: clinicaltrials.gov

Share:
Add to list

Preconceptional Period and Transtheoretically Based Education

Study ID: NCT06765304
Start Date: 2025-09-30
End Date: 2025-12-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

108

Intervention / Treatment

Transtheoretical education intervention group

Preconceptional Period Healthy Life Behaviours Classical Education Intervention Group

Placebo

Sponsor

Ankara Medipol University

Source: clinicaltrials.gov

Share:
Add to list

The SetPoint System as a Pro-Remyelination Therapy for Relapsing-Remitting Multiple Sclerosis: A Pilot Study

Study ID: NCT06796504
Start Date: 2025-09-30
End Date: 2030-09-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

60

Intervention / Treatment

Procedure/Surgery: Implant Procedure

Disease-Modifying Therapies (DMTs)

Device: Active stimulation

Device: Non-active stimulation

Sponsor

SetPoint Medical Corporation

Source: clinicaltrials.gov

Share:
Add to list

Genetic Ablation of CD33 in HSC to Broaden the Therapeutic Index of CD33-directed Immunotherapy in Patients with AML

Study ID: NCT05662904
Start Date: 2028-01
End Date: 2030-01
Study Type

Interventional

Study Phase

Phase1

No. of Participants

12

Intervention / Treatment

Donor-derived CD34+ HSC with CRISPR/Cas9-mediated CD33 deletion

Gemtuzumab ozogamicin

Sponsor

German Cancer Research Center

Source: clinicaltrials.gov

Share:
Add to list

Effect Of Percutaneous Electrical Nerve Field Stimulation on Symptom Control/Nervous System Activity in Patients w/Diabetes Types 1/2

Study ID: NCT06783504
Start Date: 2026-02-10
End Date: 2027-08
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

60

Intervention / Treatment

PERCUTANEOUS ELECTRICAL FIELD NERVE STIMULATION

Sham percutaneous electrical nerve field stimulation

Sponsor

Indiana University

Source: clinicaltrials.gov

Share:
Add to list

Early Aggressive Strategy for Treatment of Lipid-Lowering in Acute Ischemic Stroke Delivered With Endovascular Therapy for Large Artery Occlusion

Study ID: NCT07002476
Start Date: 2025-06-30
End Date: 2029-01-01
Study Type

Interventional

Study Phase

Phase3

No. of Participants

652

Intervention / Treatment

guideline-recommended SoC

Recaticimab (intensive)

Sponsor

Shanghai East Hospital

Source: clinicaltrials.gov

Share:
Add to list

A Study of CBX-250 in Participants With Acute Myeloid Leukemia, High-Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia

Study ID: NCT06994676
Start Date: 2025-07
End Date: 2027-06
Study Type

Interventional

Study Phase

Phase1

No. of Participants

72

Intervention / Treatment

CBX-250

Sponsor

Crossbow Therapeutics, Inc.

Source: clinicaltrials.gov

Share:
Add to list

Study to Understand the Genetic Risk of Developing an Immune Response After Blood Transfusions Among Individuals With Sickle Cell Disease

Study ID: NCT06944067
Start Date: 2025-07-10
End Date: 2030-04-10
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

50

Intervention / Treatment
Sponsor

National Human Genome Research Institute (NHGRI)

Source: clinicaltrials.gov

Share:
Add to list